Holmgren D, Engström I, Bjure J, Sixt R, Aberg N
Department of Pediatrics I, University of Göteborg, East Hospital, Sweden.
Pediatr Pulmonol. 1993 Mar;15(3):168-74. doi: 10.1002/ppul.1950150308.
Bronchial reactivity was assessed in 66 children with bronchial asthma (aged 8-15 years) by provocation with histamine-HCl during a symptom-free period. A significant bronchial reaction to histamine was defined as a 50% increase in the resistance of the respiratory system (Rrs) determined by the forced oscillation technique. The provocative dose causing a 50% increase in the Rrs (PD50Rrs) was interpolated from the log dose-response curve. The mean PD50Rrs was significantly lower in children with asthma (0.22 mg/mL) compared with a group of healthy children in the same age range (1.55 mg/mL) (P < 0.001). In children with clinically severe asthma, the mean PD50Rrs was lower (0.13 mg/mL) than in children with mild asthma (0.34 mg/mL) (P < 0.001). Transcutaneous PO2 (PtcO2) was monitored in 25 of the children with asthma. In this group the proportion of mild and severe asthma, the baseline lung function variables, and the PD50Rrs were not significantly different from those of the whole group of children. During the reaction, the PtcO2 fell on average by 29% of the baseline value (P < 0.001); in 88% of the children, the fall in PtcO2 was 20% or more of the baseline value. We conclude that histamine provocation tests using the forced oscillation technique and transcutaneous PO2 to assess a bronchial reaction have a good discriminatory capacity for different degrees of clinical severity of asthma in children.
在症状缓解期,通过用盐酸组胺激发试验对66名支气管哮喘儿童(年龄8 - 15岁)的支气管反应性进行评估。对组胺的显著支气管反应定义为通过强迫振荡技术测定的呼吸系统阻力(Rrs)增加50%。引起Rrs增加50%的激发剂量(PD50Rrs)从对数剂量反应曲线中插值得到。与同年龄范围的健康儿童组(1.55 mg/mL)相比,哮喘儿童的平均PD50Rrs显著更低(0.22 mg/mL)(P < 0.001)。在临床重度哮喘儿童中,平均PD50Rrs(0.13 mg/mL)低于轻度哮喘儿童(0.34 mg/mL)(P < 0.001)。对25名哮喘儿童进行了经皮氧分压(PtcO2)监测。在该组中,轻度和重度哮喘的比例、基线肺功能变量以及PD50Rrs与整个哮喘儿童组相比无显著差异。在反应过程中,PtcO2平均下降至基线值的29%(P < 0.001);在88%的儿童中,PtcO2下降幅度为基线值的20%或更多。我们得出结论,使用强迫振荡技术和经皮氧分压来评估支气管反应的组胺激发试验对儿童哮喘不同程度的临床严重程度具有良好的鉴别能力。